Continuous use of antipsychotics and its association with mortality and hospitalization in institutionalized Chinese older adults: An 18-month prospective cohort study

International Psychogeriatrics

Volumn 23, Issue 10, 2011, Pages 1640-1648

  Chan, Tuen Ching ^a,b   Luk, James Ka Hay ^a   Shea, Yat Fung ^a,b   Lau, Ka Hin ^b   Chan, Felix Hon Wai ^a   Yu, Gabriel Ka Kui ^b   Chu, Leung Wing ^a,b  

^a Fung Yiu King Hospital   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antipsychotics; hospitalization; institutionalized elderly; mortality; nursing home

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; INFLUENZA VACCINE; NEUROLEPTIC AGENT; PNEUMOCOCCUS VACCINE; QUETIAPINE;

2009 H1N1 INFLUENZA; ABBREVIATED MENTAL TEST; AGED; ARTICLE; BARTHEL INDEX; BEHAVIOR DISORDER; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOM; CHARLSON COMORBIDITY INDEX; CHINESE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DEMENTIA; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL TEST; MORTALITY; NURSING HOME; NURSING HOME PATIENT; PANDEMIC INFLUENZA; PNEUMOCOCCAL INFECTION; PSYCHOPHARMACOTHERAPY; SCORING SYSTEM; SEASONAL INFLUENZA; VACCINATION;

AGED; AGED, 80 AND OVER; AGING; ANTIPSYCHOTIC AGENTS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HOSPITALIZATION; HUMANS; MALE; NURSING HOMES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80455174607     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S104161021100175X     Document Type: Article

References (30)

1. Amiel, J. M., Manguria, C. V., Ganguli, R. and Newcomer, J. W. (2008).Addressing cardiometabolic risk during treatment with antipsychotic medications. Current Opinion in Psychiatry, 21, 613-618.
2. Ballard, C. et al. (2009).The dementia antipsychotic withdrawal trial (DART-AD): long term follow up of a randomized placebo-controlled trial. Lancet Neurology, 2, 151-156.
3. Bird, M., Jones, R. H., Korten, A. and Smithers, H. (2007).A controlled trial of a predominantly psychosocial approach to BPSD: treating causality. International Psychogeriatrics, 19, 874-891.
4. Bridges-Parlet, S., Knopman, D. and Steffes, S. (1997).Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study. Journal of Geriatric Psychiatry and Neurology, 10, 119-126.
5. Bronskill, S. E. et al. (2009).The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality. Medical Care, 47, 1000-1008.
6. Charlson, M. E., Pompei, P., Ales, K. L. and MacKenzie, C. R. (1987).A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases, 40, 373-383.
7. Chu, L.W., Pei, C. K. W.,Ho, M. H. and Chan, P. T. (1995).Validation of the Abbreviated Mental Test (Hong Kong version) in the elderly medical patient. Hong Kong Medical Journal, 1, 207-211.
8. DeYoung, S., Just, G. and Harrison, R. (2002).Decreasing aggressive, agitated, or disruptive behavior: participation ina behavior management unit. Journal of Gerontological Nursing, 28, 22-31.
9. Kales, H. C. et al. (2008).Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications. Evidence-Based Mental Health, 11, 73.
10. Liperoti, R. et al. (2009).All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. Journal of Clinical Psychiatry, 70, 1340-1347.
11. Lonergan, E., Luxenberg, J. and Colford, J. (2002).Haloperidol for agitation in dementia. Cochrane Database Systematic. Review, 2, CD002852.
12. Luk, J. K. H., Chiu, P. K. C. and Chu, L. W. (2009) Factors affecting institutionalization in older Chinese patients after rehabilitation from acute medical problems.Archives of Gerontology and Geriatrics, 49, 110-114.
13. Mahoney, F. and Barthel, D. (1965).Functional evaluation: the Barthel Index. Maryland State Medical Journal, 14, 61-65.
14. Mok, W. Y. W., Chu, L. W., Chung, C. P., Chan, N. Y. and Hui, S. L. (2004).The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease. International Journal of Geriatric Psychiatry, 19, 1040-1046.
15. Nordon, C. et al. (2009).Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case control study. American Journal of Geriatric Psychiatry, 17, 1059-1067.
16. Raivio, M. M., Laurila, J. V., Strandberg, T. E. and Tilvis, R. S. (2007).Neither atypical nor conventional antipsychotics increase mortality or hospital admission among elderly patients with dementia: a two year prospective study. American Journal of Geriatric Psychia ry,15, 416-424.
17. Rossom, R. C., Rector, T. S., Lederle, F. and Dysken, M. W. (2010).Are all commonly prescribed anti-psychotics associated with greater mortality in elderly male veterans with dementia? Journal of the American Geriatrics Society, 58, 1027-1034.
18. Schneeweiss, S. and Maclure, M. (2000).Use of comorbidity scores for control of confounding in studies using administrative databases. International Journal of Epidemiology, 29, 891-898.
19. Schneider, L. S., Pollock, V. E. and Lyness, S. A. (1990).A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society, 38, 553-563.
20. Schneider, L. S., Dagerman, K. S. and Insel, P. (2005).Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 15, 1934-1943.
21. Sicouri, S. and Antzelevitch, C. (2008).Sudden cardiac death secondary to antidepressants and antipsychotics drug. Expert Opinion on Drug Safety, 7, 181-194.
22. Simoni-Wastila, L., Ryder, P. T., Qian, J., Zuckerman, I. H., Shaffer, T. and Zhao, L. (2009).Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long term care facilities. American Journal of Geriatric Psychiatry, 17, 417-427.
23. Tang, M. et al. (2010).Utilization of emergency room and hospitalization by Chinese nursing home residents: a cross-sectional study. Journal of the American Medical Directors Association, 11, 325-332.
24. Testad, I., Aasland, A. M. and Aarsland, D. (2007).Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 916-921.
25. Tondi, L., Ribani, L., Bottazzi, M., Viscomi, G. and Vulcano, V. (2007).Validation therapy (VT) in nursing homes: a case-control study. Archives of Gerontological Geriatrics, 44, 407-411.
26. Torres Moreno, B. and Fernandez Duque, O. (2010).Barthel and Charlson indexes for the prognosis of mortality and institutionalization in hospitalized geriatric patients. Revista Española de Geriatría y Gerontología, 45, 111-116.
27. Trifiro, G., Verhamme, K. M. C., Ziere, G., Caputi, A. P., Stricker, B. H. and Sturkenboom, C. J. (2007).All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538-544.
28. van Reekum, R. et al. (2002).A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. International Psychogeriatrics, 14, 197-210.
29. Wang, P. S. et al. (2005).Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine, 22, 2335-2341.
30. Zuidema, S. U., Derken, E., Verhey, F. R. and Koopmans, R. T. (2007).Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 22, 632-638.